Graphene Ventures

Graphene Ventures is a Bay Area early-stage venture firm with a generalist software thesis and a graphenevc.com website and public profile that does not surface specific healthcare or AI sector focus or check size discipline. The firm has historical association with technology investing across consumer and enterprise software. For healthcare AI founders, Graphene is a peripheral generalist fund best treated as potential syndicate capital rather than a thesis-aligned lead investor. Plausible check sizes for partnerships of this profile run 100K to 750K at seed, supporting rounds led by larger or more specialized firms. Founders building horizontal AI software with healthcare applications, or healthcare-flavored B2B SaaS with strong generalist software metrics, could open a conversation. Founders building regulated medtech, therapeutics, or clinical AI requiring deep healthcare networks should look at healthcare-native firms. Entry path is LinkedIn direct outreach to partners with a tight, generalist-friendly pitch focused on team, traction, and market opportunity. Do not expect deep healthcare-specific diligence or sector value-add; expect a generalist read on standard B2B SaaS metrics. Realistic founder triage: spend warm-introduction time on healthcare-specialist firms first, and approach Graphene as a syndicate participant once a thesis-aligned lead investor is committed. Treat any check as additive capital and avoid handing them governance influence given the absence of demonstrated healthcare expertise. The honest read for healthcare AI founders is that small Bay Area generalist seed funds without published healthcare focus offer limited differentiated value; the capital is fungible, the network is generic, and the diligence is not domain-specific. Allocate fundraising hours to funds that bring something specific to your business.